• ANGEL PEÑA

Updated Thursday, December 5, 2019 - 10:50 pm

  • Share on Facebook
  • Share on Twitter
  • Send by email

Something fat had been cooking at Grifols for some time. This Friday, its scientific chefs are scheduled to be crowned in California, the innovation mecca. The Catalan pharmaceutical company, which started with a small laboratory in 1909 and has become a multinational with all the letters, presents this Friday at the International Conference of Clinical Trials on Alzheimer's Disease in San Diego the latest update of its Ambar study, Acronym for Alzheimer Management by Albumin Rep

To continue reading, become Premium

Are you already Premium? Log in

Monthly

Launching offer

€ 1

first month

after € 7.99

I want it

Discover what is Premium

Cancel whenever you want

Check the terms and conditions of the service

According to the criteria of The Trust Project

Know more